AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth Conference Canaccord Genuity Global Growth Conference 2013 Business Wire CAMBRIDGE, Mass. -- August 9, 2013 AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Canaccord Genuity 33^rd Annual Growth Conference on Thursday, August 15, 2013 at 2:00 p.m. (ET) in Boston. A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation. About AVEO AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveooncology.com. Contact: AVEO Oncology David Johnston, 617-299-5810 or Pure Communications Kristie Wallis, 336-774-8666
AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth Conference
Press spacebar to pause and continue. Press esc to stop.